Growth Focus: Decmil Group Ltd (DCG)

by Patrick Taylor

Date of Data Capture: 10/10/2016


Classification: Construction & Engineering

Current Price: $1.09

Market Capitalisation: $179M

Forecast EBITDA Growth: 43.43%

Gross Yield: 3.32%

Consensus Price Target: $0.86

# Covering Analysts: 2

Premium at Current Price: 21.1%

Price Target Trend: Increasing

Signal Time Frame: Monthly-Weekly

Trend Bias: Up-Down Long-Short

Short-term: Positive Neutral
Medium-term: Positive
Long-term: Positive

Recommendation: Buy
Focus: Dividend Income & Capital Growth

Set up Notes:
• DCG looks to be in the early stage of a major trend reversal with improving fundamentals and while volatility will be significant so too will the returns if the call is right.
• Good long-term signalling has had our eye on them for a little while now and with the break of $1.00 structural resistance as well as linear resistance 2 weeks ago we think it is time to step forward on this trade.
• Some dynamic resistance around $1.12 is yet to be conquered and should provide some short-term volatility as it looks to test its major dynamic resistance target around $1.40. If it breaks that it could well be a longer-term hold.
• Decent support down to $1.00, any bounce off that should be a good buying opportunity, with further support layered down to 80c.

Growth Focus: Decmil Group Ltd

Our primary focus here is capital gain, we will select our stocks from the ASX top 500 All Ordinaries Index.

When you aren’t investing directly in strength you at least should be buying the end of weakness. Here we are looking to climb the latter to success with construction engineer Decmil Group Ltd (DCG) as they continue digging themselves out of a financial black hole with strongly improving fundamentals and an exciting technical blueprint.

First breaking ground in Perth 1979, Decmil has grown to be a significant player in the fields of engineering, construction, design, fabrication and maintenance. Accordingly their share price experienced as many up and downs as the business they practice, but with the price and performance of the company continuing to improve we believe they are currently building towards a greater recovery.

While they do pay a significant dividend right now we prefer to treat this stock as a recovery growth play and look to recent contract wins and strategic acquisitions to back excellent forecasts as Decmil engineers a return to robust earnings and excellent forward growth potential. We have to note that while current pricing has them rising above their present consensus price target by around 21%, those aggregate price targets rose by a similar 21% in the last two months alone.

Improving fundamentals do indeed put solid foundations under this stock, but really we are looking for clear technical signalling with high correlation to give us confidence that they are really bridging the gap to further price growth. And we have that here in spades.

The long-term trend began signalling a positive reversal back in June 2016 and was soon followed by a shorter-termed rally into August before successfully retesting that breakout in September. Waiting for the medium-term downtrend to complete lasted until a week ago when that signal turned positive while the price broke through important structural resistance at $1.00 and dynamic resistance sitting closely overhead at $1.02. While there will be volatility during the emergence of this uptrend, the potential here is easy to project going ahead.

Looking back at their price history you can survey a company that falls deeply before making arching rallies in recovery. We believe this could be happening again with previous similar long-term (monthly) buy signals preceding rallies of around 500% in 2009, 100% in 2010, 40% in 2012 and 50% in 2013 – with each one of these rallies following steep falls. And right now they seem to be emerging from their largest collapse in price to date.

There does remain some dynamic resistance currently layered around $1.40 which will be hardened by structural resistance set in place back in 2013 and 2010 - but these levels should also act as natural targets. With this background, combined with sturdy fundamentals supporting exciting technical signalling the time is now to back Decmil as they look to rebuild shareholder value.


This report was produced by Taylor Securities Pty Ltd, which is a Corporate Authorised Representative (Number 414063) of Bespoke Portfolio Pty Ltd (AFSL 341991). Taylor Securities and Patrick Taylor (Representative number 414064) have made every effort to ensure that the information and material contained in this report is accurate and correct and has been obtained from reliable sources. However, no representation is made about the accuracy or completeness of the information and material and it should not be relied upon as a substitute for the exercise of independent judgment. Except to the extent required by law, Taylor Securities and Patrick Taylor does not accept any liability, including negligence, for any loss or damage arising from the use of, or reliance on, the material contained in this report. This report is for information purposes only and is not intended as an offer or solicitation with respect to the sale or purchase of any securities or financial products. The securities or financial products recommended by Taylor Securities and Patrick Taylor carry no guarantee with respect to return of capital or the market value of those securities or financial products. There are general risks associated with any investment in securities or financial products. Investors should be aware that these risks might result in loss of income and capital invested. Neither Taylor Securities and Patrick Taylor nor any of its associates guarantees the repayment of capital. WARNING: This report is intended to provide general financial product advice only. It has been prepared without having regarded to or taking into account any particular investor’s objectives, financial situation and/or needs. Accordingly, no recipients should rely on any recommendation (whether express or implied) contained in this document without obtaining specific advice from their advisers. All investors should therefore consider the appropriateness of the advice, in light of their own objectives, financial situation and/or needs, before acting on the advice. Where applicable, investors should obtain a copy of and consider the product disclosure statement for that product (if any) before making any decision.

Subscribe to our Daily Newsletter?

Would you like to receive our daily news to your inbox?